\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ \ \(4\)\
\-\ vitals\\:\\ wnl\\,\\ normotensive\\,\\ gen\\:\\ normal\\ appearing\\ female\\ consistent\\ with\\ stated\\ age\\.\\ a\\&o\\,\\ no\\ aniridia\\ or\\ hemihypertrophy\\ seen\\.\\ several\\ small\\ caf\\Ã\\©\\ au\\ lait\\ spots\\ scattered\\ across\\ trunk\\ each\\ less\\ then\\ 2cm\\.\\ abdominal\\ exam\\ shows\\ mildly\\ distended\\ abdomen\\ with\\ bilateral\\ palpable\\ flank\\ masses\\.\\ gu\\ exam\\:\\ tanner\\ stage\\ 1\\.\\ remainder\\ of\\ exam\\ wnl\ \(0\)\
\-\ lab\\ work\\:\ \(0\)\
\-\ cbc\\:\\ wbc\\:\\ 6\\.8\\,\\ hgb\\:13\\ plt\\:378\\,000\ \(0\)\
\-\ u\\/a\\:\\ wnl\ \(0\)\
\-\ cmp\\:wnl\ \(0\)\
\-\ our\\ patient\\ was\\ diagnosed\\ with\\ stage\\ 5\\ wilms\\ tumor\\ as\\ her\\ disease\\ was\\ present\\ bilaterally\\.\\ \\ prior\\ to\\ her\\ several\\ kidney\\ surgeries\\ the\\ patient\\ underwent\\ several\\ rounds\\ of\\ chemotherapy\\ including\\ actinomycin\\ and\\ vincristine\\ in\\ hopes\\ of\\ shrinking\\ the\\ kidney\\ and\\ allowing\\ for\\ sparing\\ of\\ some\\ of\\ its\\ function\\.\\ \\ the\\ patient\\ then\\ underwent\\ l\\ radical\\ nephrectomy\\ with\\ r\\ partial\\ nephrectomy\\.\\ \\ she\\ is\\ followed\\ closely\\ with\\ hematology\\ and\\ oncology\\ as\\ well\\ as\\ urology\\.\\ \\ she\\ will\\ require\\ recurrent\\ ultrasounds\\ and\\ ct\\ scans\\ to\\ monitor\\ for\\ recurrence\\ of\\ disease\\.\\ \\ regular\\ follow\\ up\\ with\\ her\\ pcp\\ is\\ suggested\\ for\\ routine\\ physical\\ exams\\ and\\ evaluation\\ of\\ patients\\ current\\ symptoms\\.\\ \\ abnormalities\\ in\\ either\\ of\\ these\\ screening\\ measures\\ may\\ indicate\\ reoccurrence\\ may\\ indicate\\ reoccurrence\\.\\ patient\\ symptoms\\ should\\ be\\ followed\\ as\\ well\\ as\\ these\\ may\\ indicate\\ recurrence\\ of\\ disease\\.\ \(0\)\
\-\ 1\\)ct\\ of\\ chest\\,\\ abdomen\\,\\ and\\ pelvis\\ with\\ contrast\\,\\ \ \(0\)\
\-\ the\\ right\\ kidney\\ apparently\\ has\\ a\\ single\\ mass\\.\\ it\\ is\\ measured\\ at\\ 5\\ x\\ 5\\.7x\\ 5\\.6\\ cm\\.\\ the\\ remainder\\ of\\ the\\ right\\ kidney\\ appears\\ to\\ enhance\\ and\\ excrete\\ normally\\.\\ the\\ right\\ renal\\ collecting\\ system\\ does\\ not\\ appear\\ to\\ be\\ involved\\.\\ the\\ left\\ kidney\\ is\\ much\\ more\\ difficult\\ to\\ evaluate\\.\\ there\\ are\\ at\\ least\\ seven\\ left\\ renal\\ masses\\.\\ the\\ largest\\ mass\\ on\\ the\\ left\\ anterior\\ and\\ off\\ the\\ inferior\\ pole\\.\\ it\\ measures\\ 5\\.5\\ x\\ 4\\.9\\ x\\ 4\\.1\\ cm\\.\\ this\\ mass\\ is\\ the\\ most\\ heterogenous\\ and\\ may\\ be\\ more\\ vascular\\ than\\ the\\ remainder\\ of\\ the\\ masses\\.\\ a\\ second\\ mass\\ is\\ identified\\ superior\\ and\\ about\\ the\\ same\\ level\\ anteriorly\\ on\\ the\\ right\\ kidney\\.\\ this\\ measures\\ 3\\.3\\ x\\ 3\\.0\\ x\\ 2\\.4\\ cm\\.\\ on\\ the\\ ultrasound\\ i\\ believe\\ that\\ the\\ masses\\ were\\ multi\\-\\ lobulated\\,\\ but\\ i\\ believe\\ they\\ actually\\ are\\ separate\\ masses\\.\\ a\\ second\\ inferior\\ pole\\ mass\\ measures\\ 3\\.7\\ x\\ 4\\.3\\ x\\ 4\\.1\\ cm\\.\\ smaller\\ masses\\ are\\ identified\\ in\\ the\\ left\\ kidney\\,\\ more\\ posteriorly\\,\\ measuring\\ approximately\\ 12\\ x\\ 12\\ mm\\,\\ 11\\ x\\ 16\\ mm\\ and\\ 21\\ x\\ 18\\ mm\\.\\ i\\ see\\ no\\ evidence\\ of\\ free\\ fluid\\ in\\ the\\ pelvis\\.\\ there\\ is\\ no\\ definite\\ mesenteric\\ adenopathy\\.\\ the\\ bladder\ \(0\)\
\-\ is\\ unremarkable\\.\\ i\\ see\\ no\\ evidence\\ of\\ enlarged\\ inguinal\\ nodes\\.\\ there\\ is\\ shotty\\ inguinal\\ adenopathy\\ bilaterally\\.\ \(0\)\
\-\ 2\\)abdominal\\ ultrasound\\:\\ the\\ left\\ kidney\\ is\\ outside\\ two\\ standard\\ deviations\\ of\\ normal\\ in\\ size\\.\\ \\ it\\ measures\\ 5\\.7\\ cm\\ in\\ longest\\ dimension\\ with\\ 9\\ cm\\ being\\ upper\\ limits\\ of\\ normal\\ for\\ this\\ age\\.\\ \\ inferior\\ to\\ the\\ spleen\\ there\\ is\\ a\\ solid\\ appearing\\ mass\\ which\\ appears\\ to\\ adjoin\\ the\\ left\\ kidney\\.\\ this\\ mass\\ is\\ echogenic\\ in\\ nature\\ and\\ multi\\-lobulated\\.\\ it\\ measures\\ 8\\.4\\ x\\ 4\\.3\\ x\\ 7\\.1\\ cm\\.\\ inferior\\ to\\ the\\ mass\\ there\\ is\\ relatively\\ normal\\ appearing\\ left\\ kidney\\.\\ the\\ measurements\\ stated\\ for\\ the\\ left\\ kidney\\ include\\ only\\ the\\ normal\\ portion\\ of\\ the\\ kidney\\.\\ \\ images\\ of\\ the\\ right\\ kidney\\ also\\ demonstrate\\ a\\ solid\\ appearing\\ mass\\ off\\ the\\ superior\\ pole\\.\\ the\\ right\\ kidney\\ measures\\ 7\\.4\\ cm\\ in\\ longest\\ dimension\\ without\\ the\\ addition\\ of\\ the\\ mass\\.\\ the\\ mass\\ measures\\ 5\\.5\\ x\\ 3\\.1\\ x\\ 4\\.8\\ cm\\.\\ it\\ again\\ is\\ echogenic\\ and\\ solid\\ in\\ appearance\\ suggesting\\ a\\ solid\\ renal\\ tumor\\.\\ the\\ inferior\\ portion\\ of\\ the\\ right\\ kidney\\ is\\ more\\ normal\\ in\\ appearance\\,\\ without\\ evidence\\ of\\ hydronephrosis\\,\\ echogenic\\ focus\\ to\\ suggest\\ a\\ stone\\,\\ or\\ perinephric\\ fluid\\ collections\\.\ \(0\)\
\-\ nephroblastomatosis\\ with\\ bilateral\\ wilms\\ tumors\ \(0\)\
\-\ neuroblastoma\ \(81\)\
\-\ hydronephrosis\ \(122\)\
\-\ multicystic\\ dysplastic\\ kidney\ \(3\)\
\-\ multilocular\\ cystic\\ nephroma\ \(0\)\
\-\ renal\\ vein\\ thrombosis\ \(4\)\
\-\ pckd\ \(0\)\
\-\ congenital\\ mesoblastic\\ nephroma\ \(2\)\
\-\ adrenal\\ hemorrage\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ pt\\ is\\ a\\ 3\\ y\\.o\\ female\\ who\\ presented\\ to\\ pcp\\ with\\ distended\\ abdomen\\ and\\ mild\\ constipation\\ x\\ 2\\-3\\ weeks\\.\\ \\ denies\\ nausea\\,\\ vomiting\\,\\ fever\\,\\ chills\\.\\ \\ the\\ patient\\ denies\\ weight\\ loss\\,\\ night\\ sweats\\,\\ and\\ hematuria\\.\\ \\ no\\ significant\\ pmh\\.\\ \\ the\\ patient\\ was\\ then\\ sent\\ for\\ ultrasound\\,\\ which\\ showed\\ bilateral\\ enlargement\\ of\\ the\\ kidneys\\ with\\ solid\\ masses\\ in\\ both\\,\\ confirmed\\ by\\ ct\\.\\ she\\ was\\ referred\\ to\\ urology\\ for\\ further\\ evaluation\\.\ \(0\)\
\-\ path\\ report\\:\ \(0\)\
\-\ a\\.\\ specimen\\:\\ l\\ radical\\ nephrectomy\\:\ \(0\)\
\-\ microscopic\\ examination\\:\ \(0\)\
\-\ tumor\\ cells\\ in\\ the\\ yellow\\ area\\ resemble\\ those\\ of\\ the\\ previous\\ renal\\ biopsy\\.\\ a\\ triphasic\\ tumor\\ with\\ a\\ prominent\\ blastemal\\ component\\ is\\ present\\.\\ \\ in\\ the\\ adjacent\\ grey\\-white\\ to\\ brown\\ areas\\,\\ the\\ tumor\\ shows\\ more\\ prominent\\ epithelial\\ components\\ with\\ prominent\\ pleomorphism\\.\\ \\ the\\ stromal\\ component\\ in\\ both\\ areas\\ is\\ much\\ less\\ prominent\\ compared\\ to\\ the\\ previous\\ partial\\ right\\ nephrectomy\\.\\ \\ multifocal\\ perilobar\\ nephrogenic\\ rests\\ are\\ present\\ adjacent\\ to\\ the\\ tumor\\ and\\ elsewhere\\ in\\ the\\ upper\\ pole\\.\\ \\ the\\ largest\\ upper\\ pole\\ lesion\\ shows\\ additional\\ papillary\\ change\\.\\ \\ a\\ microscopic\\ foci\\ of\\ tumor\\ is\\ present\\ on\\ the\\ surface\\ of\\ this\\ lesion\\ and\\ is\\ interpreted\\ as\\ contamination\\.\\ \\ no\\ extra\\ capsular\\ tumor\\ is\\ appreciable\\ in\\ the\\ lower\\ pole\\ lesions\\.\\ \\ intracapsular\\ metastatic\\ tumor\\ is\\ seen\\ fairly\\ frequently\\ in\\ the\\ tumor\\ blocks\\ and\\ 3\\ of\\ 10\\ lymph\\ nodes\\ sections\\ form\\ the\\ hilar\\ region\\.\\ \\ focal\\ subcapsular\\ metastatic\\ tumor\\ is\\ also\\ present\\ in\\ these\\ affected\\ lymph\\ nodes\\.\\ \\ the\\ hilar\\ vascular\\ and\\ ureteral\\ surgical\\ margins\\ show\\ no\\ appreciable\\ tumor\\.\\ \\ \ \(0\)\
\-\ final\\ diagnosis\\:\\ \ \(0\)\
\-\ 1\\.wilms\\ tumor\\ s\\/p\\ chemotherapy\ \(0\)\
\-\ 2\\.nephroblastomatosis\\ s\\/p\\ chemotherapy\ \(0\)\
\-\ 3\\.intracapsular\\ metastatic\\ tumor\\,\\ kidney\ \(0\)\
\-\ 4\\.intracapsular\\ and\\ sub\\-capsular\\ metastatic\\ tumor\\,\\ hilar\\ lymph\\ nodes\\.\ \(0\)\
\-\ b\\.\\ specimen\\:\\ r\\ partial\\ nephrectomy\ \(0\)\
\-\ microscopic\\ evaluation\ \(1\)\
\-\ permanent\\ sections\\ show\\ renal\\ tissue\\,\\ a\\ thick\\ fibrous\\ capsule\\ and\\ adjacent\\ nephroblastoma\\ with\\ blastemal\\ areas\\ and\\ extensive\\ tubular\\ areas\\.\\ \\ abundant\\ lymphocytic\\ infiltrate\\ is\\ observed\\ in\\ this\\ area\\.\\ \\ inked\\ margins\\ show\\ capsular\\ surface\\ free\\ of\\ neoplasm\\.\\ medial\\ edge\\ of\\ kidney\\ section\\ shows\\ tubular\\ nephroblastoma\\ infiltrating\\ margins\\ of\\ excision\\ focally\\.\ \(0\)\
\-\ final\\ diagnosis\\:\ \(0\)\
\-\ 1\\)\\	wilms\\ tumor\\ with\\ favorable\\ histology\ \(0\)\
\-\ 2\\)\\	renal\\ medial\\ edge\\ with\\ focal\\ nephroblastoma\\ at\\ margin\\ of\\ excision\ \(0\)\
\-\ final\\ diagnosis\\:\\ bilateral\\ wilms\\ tumors\\ with\\ areas\\ of\\ nephroblastomatosis\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ kidney\\:\\ 0\\.3302193229042509\ \(0\)\
\-\ the\\:\\ 0\\.28136920333754206\ \(0\)\
\-\ tumor\\:\\ 0\\.21853996851903412\ \(0\)\
\-\ is\\:\\ 0\\.17163102249696452\ \(0\)\
\-\ measures\\:\\ 0\\.17032524013037367\ \(0\)\
\-\ of\\:\\ 0\\.15841770788004672\ \(0\)\
\-\ wilms\\:\\ 0\\.1432914445179767\ \(0\)\
\-\ pole\\:\\ 0\\.1365496946790723\ \(0\)\
\-\ cm\\:\\ 0\\.13497425293344872\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.13336601914522106\ \(0\)\
\-\ masses\\:\\ 0\\.12444183179629459\ \(0\)\
\-\ in\\:\\ 0\\.12342648219427713\ \(0\)\
\-\ and\\:\\ 0\\.11871166285512369\ \(0\)\
\-\ renal\\:\\ 0\\.1138302374028526\ \(0\)\
\-\ mass\\:\\ 0\\.10972023415343186\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.10462639068883735\ \(0\)\
\-\ nephroblastoma\\:\\ 0\\.10462639068883735\ \(0\)\
\-\ intracapsular\\:\\ 0\\.10187051883198758\ \(0\)\
\-\ solid\\:\\ 0\\.10009860624042999\ \(0\)\
\-\ wnl\\:\\ 0\\.0979598236846158\ \(0\)\
\-\ capsular\\:\\ 0\\.09174084760951631\ \(0\)\
\-\ to\\:\\ 0\\.09139567832468395\ \(0\)\
\-\ inferior\\:\\ 0\\.08882638998321293\ \(0\)\
\-\ nodes\\:\\ 0\\.08873277899215644\ \(0\)\
\-\ areas\\:\\ 0\\.08864544958168573\ \(0\)\
\-\ microscopic\\:\\ 0\\.08809186500628617\ \(0\)\
\-\ with\\:\\ 0\\.08692613423183404\ \(0\)\
\-\ appearing\\:\\ 0\\.08346501148304271\ \(0\)\
\-\ prominent\\:\\ 0\\.08226536871153302\ \(0\)\
\-\ longest\\:\\ 0\\.07980931218624139\ \(0\)\
\-\ blastemal\\:\\ 0\\.07980931218624139\ \(0\)\
\-\ indicate\\:\\ 0\\.07976761717009169\ \(0\)\
\-\ final\\:\\ 0\\.07685375978345815\ \(0\)\
\-\ reoccurrence\\:\\ 0\\.07513242947199394\ \(0\)\
\-\ echogenic\\:\\ 0\\.07183478926429705\ \(0\)\
\-\ hilar\\:\\ 0\\.07183478926429705\ \(0\)\
\-\ more\\:\\ 0\\.07169485309914314\ \(0\)\
\-\ left\\:\\ 0\\.0712624095612405\ \(0\)\
\-\ right\\:\\ 0\\.0692609989115412\ \(0\)\
\-\ remainder\\:\\ 0\\.06893949179408837\ \(0\)\
\-\ present\\:\\ 0\\.06699779926609595\ \(0\)\
\-\ margins\\:\\ 0\\.0668387171330298\ \(0\)\
\-\ it\\:\\ 0\\.06683505415062592\ \(0\)\
\-\ nephroma\\:\\ 0\\.06638420942858908\ \(0\)\
\-\ believe\\:\\ 0\\.06507404441164412\ \(0\)\
\-\ normal\\:\\ 0\\.06397120428074292\ \(0\)\
\-\ as\\:\\ 0\\.06294373053361808\ \(0\)\
\-\ shows\\:\\ 0\\.06130488918660189\ \(0\)\
\-\ appreciable\\:\\ 0\\.061160565073010875\ \(0\)\
\-\ lymph\\:\\ 0\\.06091777487274515\ \(0\)\
\-\ sections\\:\\ 0\\.06077090896388137\ \(0\)\
\-\ partial\\:\\ 0\\.06035968569114815\ \(0\)\
\-\ no\\:\\ 0\\.05944213629832228\ \(0\)\
\-\ pcp\\:\\ 0\\.05842770157996668\ \(0\)\
\-\ radical\\:\\ 0\\.05785529416097524\ \(0\)\
\-\ urology\\:\\ 0\\.05731657780719069\ \(0\)\
\-\ metastatic\\:\\ 0\\.057287258763979984\ \(0\)\
\-\ bilateral\\:\\ 0\\.056136909789717165\ \(0\)\
\-\ mm\\:\\ 0\\.05606382168784362\ \(0\)\
\-\ specimen\\:\\ 0\\.055647326113984805\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.055626418316087355\ \(0\)\
\-\ then\\:\\ 0\\.05545528457567011\ \(0\)\
\-\ for\\:\\ 0\\.05540309264859877\ \(0\)\
\-\ dimension\\:\\ 0\\.053869723610195624\ \(0\)\
\-\ this\\:\\ 0\\.05383791039891332\ \(0\)\
\-\ largest\\:\\ 0\\.05317841144672779\ \(0\)\
\-\ inguinal\\:\\ 0\\.05269216249520437\ \(0\)\
\-\ edge\\:\\ 0\\.05269216249520437\ \(0\)\
\-\ may\\:\\ 0\\.052564055553517605\ \(0\)\
\-\ there\\:\\ 0\\.05195191785616582\ \(0\)\
\-\ stated\\:\\ 0\\.051648941653991816\ \(0\)\
\-\ several\\:\\ 0\\.05139857326156514\ \(0\)\
\-\ patient\\:\\ 0\\.05095998781805288\ \(0\)\
\-\ adjacent\\:\\ 0\\.05077985128850867\ \(0\)\
\-\ show\\:\\ 0\\.04973188760240115\ \(0\)\
\-\ her\\:\\ 0\\.04894224327631821\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.04846829625810419\ \(0\)\
\-\ ultrasound\\:\\ 0\\.04832142322743788\ \(0\)\
\-\ lobulated\\:\\ 0\\.04817451051856189\ \(0\)\
\-\ abdomen\\:\\ 0\\.04780031391066979\ \(0\)\
\-\ evaluation\\:\\ 0\\.047775985640432256\ \(0\)\
\-\ she\\:\\ 0\\.04663379769493695\ \(0\)\
\-\ tubular\\:\\ 0\\.04537350672247506\ \(0\)\
\-\ much\\:\\ 0\\.04523264953436065\ \(0\)\
\-\ component\\:\\ 0\\.04475604560520771\ \(0\)\
\-\ distended\\:\\ 0\\.04462430899228401\ \(0\)\
\-\ evidence\\:\\ 0\\.04446576987501973\ \(0\)\
\-\ these\\:\\ 0\\.04423845481016866\ \(0\)\
\-\ adenopathy\\:\\ 0\\.04393180787528701\ \(0\)\
\-\ off\\:\\ 0\\.0436335555533326\ \(0\)\
\-\ surface\\:\\ 0\\.04357505352272701\ \(0\)\
\-\ recurrence\\:\\ 0\\.04312002638637798\ \(0\)\
\-\ denies\\:\\ 0\\.042122161850650854\ \(0\)\
\-\ upper\\:\\ 0\\.04186355897741459\ \(0\)\
\-\ caf\\Ã\\©\\:\\ 0\\.04176078141956893\ \(0\)\
\-\ adjoin\\:\\ 0\\.04176078141956893\ \(0\)\
\-\ pckd\\:\\ 0\\.04176078141956893\ \(0\)\
\-\ stage\\:\\ 0\\.041590556593642\ \(0\)\
\-\ excision\\:\\ 0\\.04117745479528895\ \(0\)\
\-\ free\\:\\ 0\\.04065413884318174\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04061078067507327\ \(0\)\
\-\ excrete\\:\\ 0\\.039904656093120695\ \(0\)\
\-\ perilobar\\:\\ 0\\.039904656093120695\ \(0\)\
\-\ are\\:\\ 0\\.039635172305556673\ \(0\)\
\-\ previous\\:\\ 0\\.03946343266256062\ \(0\)\
\-\ exam\\:\\ 0\\.039436278586604104\ \(0\)\
\-\ second\\:\\ 0\\.0390986219869645\ \(0\)\
\-\ aniridia\\:\\ 0\\.03858771421584226\ \(0\)\
\-\ hemihypertrophy\\:\\ 0\\.03858771421584226\ \(0\)\
\-\ triphasic\\:\\ 0\\.03858771421584226\ \(0\)\
\-\ tumors\\:\\ 0\\.03840991119775437\ \(0\)\
\-\ appears\\:\\ 0\\.03824553449094314\ \(0\)\
\-\ actinomycin\\:\\ 0\\.03756621473599697\ \(0\)\
\-\ shrinking\\:\\ 0\\.03756621473599697\ \(0\)\
\-\ shotty\\:\\ 0\\.03756621473599697\ \(0\)\
\-\ pleomorphism\\:\\ 0\\.03756621473599697\ \(0\)\
\-\ portion\\:\\ 0\\.03734629939791607\ \(0\)\
\-\ identified\\:\\ 0\\.0370270565871303\ \(0\)\
\-\ hemorrage\\:\\ 0\\.036731588889394026\ \(0\)\
\-\ contamination\\:\\ 0\\.036731588889394026\ \(0\)\
\-\ inked\\:\\ 0\\.036731588889394026\ \(0\)\
\-\ pelvis\\:\\ 0\\.03652753980786896\ \(0\)\
\-\ was\\:\\ 0\\.03640291317454177\ \(0\)\
\-\ rounds\\:\\ 0\\.036025922790893984\ \(0\)\
\-\ underwent\\:\\ 0\\.035977256128934286\ \(0\)\
\-\ 12\\:\\ 0\\.03570169250192867\ \(0\)\
\-\ less\\:\\ 0\\.035530555993285175\ \(0\)\
\-\ followed\\:\\ 0\\.03526792806980233\ \(0\)\
\-\ au\\:\\ 0\\.03487546356294578\ \(0\)\
\-\ lait\\:\\ 0\\.03487546356294578\ \(0\)\
\-\ deviations\\:\\ 0\\.03487546356294578\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.03487546356294578\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03483132038783561\ \(0\)\
\-\ vascular\\:\\ 0\\.034479140944371905\ \(0\)\
\-\ hopes\\:\\ 0\\.034393147532270296\ \(0\)\
\-\ resemble\\:\\ 0\\.034393147532270296\ \(0\)\
\-\ medial\\:\\ 0\\.03399549844533246\ \(0\)\
\-\ mesoblastic\\:\\ 0\\.03395683961066253\ \(0\)\
\-\ blocks\\:\\ 0\\.03395683961066253\ \(0\)\
\-\ abundant\\:\\ 0\\.03395683961066253\ \(0\)\
\-\ superior\\:\\ 0\\.03395462544602801\ \(0\)\
\-\ area\\:\\ 0\\.03383308998918857\ \(0\)\
\-\ tanner\\:\\ 0\\.03319210471429454\ \(0\)\
\-\ rests\\:\\ 0\\.03319210471429454\ \(0\)\
\-\ disease\\:\\ 0\\.032884251724666407\ \(0\)\
\-\ normotensive\\:\\ 0\\.03285285558716731\ \(0\)\
\-\ hematology\\:\\ 0\\.03285285558716731\ \(0\)\
\-\ age\\:\\ 0\\.032788321428145015\ \(0\)\
\-\ ultrasounds\\:\\ 0\\.03253702220582206\ \(0\)\
\-\ see\\:\\ 0\\.03248811300392091\ \(0\)\
\-\ be\\:\\ 0\\.03177931217879621\ \(0\)\
\-\ spots\\:\\ 0\\.031702396359219114\ \(0\)\
\-\ multilocular\\:\\ 0\\.031702396359219114\ \(0\)\
\-\ on\\:\\ 0\\.03154660630892799\ \(0\)\
\-\ appearance\\:\\ 0\\.03148534004172822\ \(0\)\
\-\ subcapsular\\:\\ 0\\.03145488914657958\ \(0\)\
\-\ focal\\:\\ 0\\.031239539060380333\ \(0\)\
\-\ multicystic\\:\\ 0\\.03122008032854363\ \(0\)\
\-\ elsewhere\\:\\ 0\\.03122008032854363\ \(0\)\
\-\ vincristine\\:\\ 0\\.03078377240693586\ \(0\)\
\-\ focally\\:\\ 0\\.030580282536505438\ \(0\)\
\-\ measurements\\:\\ 0\\.030385454481940685\ \(0\)\
\-\ fluid\\:\\ 0\\.030154437673588157\ \(0\)\
\-\ gu\\:\\ 0\\.030019037510567875\ \(0\)\
\-\ apparently\\:\\ 0\\.030019037510567875\ \(0\)\
\-\ favorable\\:\\ 0\\.02984627103277088\ \(0\)\
\-\ ct\\:\\ 0\\.02982468533939709\ \(0\)\
\-\ allowing\\:\\ 0\\.029679788383440642\ \(0\)\
\-\ at\\:\\ 0\\.02958992227299523\ \(0\)\
\-\ permanent\\:\\ 0\\.029519148451328855\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.02936395500209539\ \(0\)\
\-\ perinephric\\:\\ 0\\.02921385078998334\ \(0\)\
\-\ both\\:\\ 0\\.029124068456020908\ \(0\)\
\-\ trunk\\:\\ 0\\.029068512604662256\ \(0\)\
\-\ cmp\\:\\ 0\\.029068512604662256\ \(0\)\
\-\ dysplastic\\:\\ 0\\.029068512604662256\ \(0\)\
\-\ path\\:\\ 0\\.02892764708048762\ \(0\)\
\-\ interpreted\\:\\ 0\\.02892764708048762\ \(0\)\
\-\ brown\\:\\ 0\\.028790987131546052\ \(0\)\
\-\ yellow\\:\\ 0\\.028658288903595345\ \(0\)\
\-\ symptoms\\:\\ 0\\.028575389041439112\ \(0\)\
\-\ abdominal\\:\\ 0\\.028564064937783403\ \(0\)\
\-\ actually\\:\\ 0\\.02852932915549245\ \(0\)\
\-\ stromal\\:\\ 0\\.02852932915549245\ \(0\)\
\-\ constipation\\:\\ 0\\.028403902999474866\ \(0\)\
\-\ seven\\:\\ 0\\.028162912184119634\ \(0\)\
\-\ closely\\:\\ 0\\.02804701312481696\ \(0\)\
\-\ epithelial\\:\\ 0\\.02804701312481696\ \(0\)\
\-\ oncology\\:\\ 0\\.02793397606518189\ \(0\)\
\-\ surgeries\\:\\ 0\\.027715945891412436\ \(0\)\
\-\ infiltrate\\:\\ 0\\.027715945891412436\ \(0\)\
\-\ histology\\:\\ 0\\.027715945891412436\ \(0\)\
\-\ without\\:\\ 0\\.027547521645858757\ \(0\)\
\-\ sparing\\:\\ 0\\.02740721533277877\ \(0\)\
\-\ fairly\\:\\ 0\\.02740721533277877\ \(0\)\
\-\ ureteral\\:\\ 0\\.027212387278214015\ \(0\)\
\-\ 2cm\\:\\ 0\\.027117996958492357\ \(0\)\
\-\ monitor\\:\\ 0\\.02667320382904421\ \(0\)\
\-\ sweats\\:\\ 0\\.02667320382904421\ \(0\)\
\-\ exams\\:\\ 0\\.02650672117971397\ \(0\)\
\-\ separate\\:\\ 0\\.02619088779836872\ \(0\)\
\-\ gen\\:\\ 0\\.02575457987676095\ \(0\)\
\-\ measured\\:\\ 0\\.02575457987676095\ \(0\)\
\-\ definite\\:\\ 0\\.025685739958173182\ \(0\)\
\-\ infiltrating\\:\\ 0\\.025617919927819383\ \(0\)\
\-\ collections\\:\\ 0\\.02555109000633053\ \(0\)\
\-\ capsule\\:\\ 0\\.02555109000633053\ \(0\)\
\-\ across\\:\\ 0\\.025420287727182744\ \(0\)\
\-\ spleen\\:\\ 0\\.025420287727182744\ \(0\)\
\-\ multifocal\\:\\ 0\\.025356261951765782\ \(0\)\
\-\ well\\:\\ 0\\.02528833468883737\ \(0\)\
\-\ female\\:\\ 0\\.02520170100756969\ \(0\)\
\-\ lesion\\:\\ 0\\.02503855178643028\ \(0\)\
\-\ thick\\:\\ 0\\.02481707850259597\ \(0\)\
\-\ each\\:\\ 0\\.02476090886145522\ \(0\)\
\-\ heterogenous\\:\\ 0\\.024596420447974086\ \(0\)\
\-\ seen\\:\\ 0\\.02458781910139475\ \(0\)\
\-\ also\\:\\ 0\\.024565854588728786\ \(0\)\
\-\ collecting\\:\\ 0\\.02448995592115395\ \(0\)\
\-\ suggested\\:\\ 0\\.02443763799948252\ \(0\)\
\-\ sent\\:\\ 0\\.02443763799948252\ \(0\)\
\-\ papillary\\:\\ 0\\.024334762471920485\ \(0\)\
\-\ standard\\:\\ 0\\.024234148129052096\ \(0\)\
\-\ adrenal\\:\\ 0\\.02418465825980843\ \(0\)\
\-\ least\\:\\ 0\\.02413569770412484\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.02399188163629716\ \(0\)\
\-\ stone\\:\\ 0\\.023852446441244995\ \(0\)\
\-\ normally\\:\\ 0\\.023806896131899565\ \(0\)\
\-\ section\\:\\ 0\\.023806896131899565\ \(0\)\
\-\ chills\\:\\ 0\\.023761794601371143\ \(0\)\
\-\ which\\:\\ 0\\.02374791475130825\ \(0\)\
\-\ components\\:\\ 0\\.02371713309278945\ \(0\)\
\-\ anteriorly\\:\\ 0\\.023672903103114533\ \(0\)\
\-\ pmh\\:\\ 0\\.023629096373420436\ \(0\)\
\-\ lab\\:\\ 0\\.02358570487963929\ \(0\)\
\-\ suggesting\\:\\ 0\\.02354272082374006\ \(0\)\
\-\ smaller\\:\\ 0\\.023500136625317542\ \(0\)\
\-\ night\\:\\ 0\\.023457944913569003\ \(0\)\
\-\ enhance\\:\\ 0\\.023374710469299956\ \(0\)\
\-\ again\\:\\ 0\\.023292962434109388\ \(0\)\
\-\ observed\\:\\ 0\\.023252629412678007\ \(0\)\
\-\ our\\:\\ 0\\.02313371965394473\ \(0\)\
\-\ hematuria\\:\\ 0\\.02309475968840823\ \(0\)\
\-\ vitals\\:\\ 0\\.023056128502871098\ \(0\)\
\-\ nature\\:\\ 0\\.023056128502871098\ \(0\)\
\-\ posteriorly\\:\\ 0\\.02301782059464205\ \(0\)\
\-\ flank\\:\\ 0\\.02290478353500698\ \(0\)\
\-\ margin\\:\\ 0\\.02290478353500698\ \(0\)\
\-\ current\\:\\ 0\\.02286771638253\ \(0\)\
\-\ form\\:\\ 0\\.022830946961399697\ \(0\)\
\-\ scattered\\:\\ 0\\.02272237819720892\ \(0\)\
\-\ scans\\:\\ 0\\.02272237819720892\ \(0\)\
\-\ regular\\:\\ 0\\.022546963314177958\ \(0\)\
\-\ mesenteric\\:\\ 0\\.022546963314177958\ \(0\)\
\-\ kidneys\\:\\ 0\\.022478637145472245\ \(0\)\
\-\ require\\:\\ 0\\.022444852724092714\ \(0\)\
\-\ those\\:\\ 0\\.022344970180173885\ \(0\)\
\-\ focus\\:\\ 0\\.02212005211496485\ \(0\)\
\-\ report\\:\\ 0\\.021996321114796755\ \(0\)\
\-\ extra\\:\\ 0\\.02193568753539957\ \(0\)\
\-\ cbc\\:\\ 0\\.021787526761363505\ \(0\)\
\-\ difficult\\:\\ 0\\.021672356704103807\ \(0\)\
\-\ pe\\:\\ 0\\.02158784165772855\ \(0\)\
\-\ either\\:\\ 0\\.02158784165772855\ \(0\)\
\-\ frequently\\:\\ 0\\.021504858690830356\ \(0\)\
\-\ affected\\:\\ 0\\.02147752864953906\ \(0\)\
\-\ foci\\:\\ 0\\.021343273622280976\ \(0\)\
\-\ work\\:\\ 0\\.02129065501629671\ \(0\)\
\-\ thrombosis\\:\\ 0\\.02129065501629671\ \(0\)\
\-\ relatively\\:\\ 0\\.02126457079575585\ \(0\)\
\-\ screening\\:\\ 0\\.021212844049693074\ \(0\)\
\-\ suggest\\:\\ 0\\.021212844049693074\ \(0\)\
\-\ function\\:\\ 0\\.021136333605987535\ \(0\)\
\-\ addition\\:\\ 0\\.021136333605987535\ \(0\)\
\-\ compared\\:\\ 0\\.02111111167816625\ \(0\)\
\-\ mildly\\:\\ 0\\.021086027953382675\ \(0\)\
\-\ outside\\:\\ 0\\.020962630500398174\ \(0\)\
\-\ recurrent\\:\\ 0\\.020938345200369256\ \(0\)\
\-\ involved\\:\\ 0\\.020938345200369256\ \(0\)\
\-\ 21\\:\\ 0\\.020866252870760677\ \(0\)\
\-\ same\\:\\ 0\\.020656547427998273\ \(0\)\
\-\ limits\\:\\ 0\\.020633828928172896\ \(0\)\
\-\ appear\\:\\ 0\\.020566342177883255\ \(0\)\
\-\ 16\\:\\ 0\\.0203483120041138\ \(0\)\
\-\ evaluate\\:\\ 0\\.020305924957581715\ \(0\)\
\-\ fibrous\\:\\ 0\\.020284877709842334\ \(0\)\
\-\ bladder\\:\\ 0\\.020263926788516615\ \(0\)\
\-\ additional\\:\\ 0\\.020243071315910556\ \(0\)\
\-\ routine\\:\\ 0\\.02022231042627166\ \(0\)\
\-\ measuring\\:\\ 0\\.02020164326557329\ \(0\)\
\-\ cells\\:\\ 0\\.02011989523038272\ \(0\)\
\-\ extensive\\:\\ 0\\.02011989523038272\ \(0\)\
\-\ single\\:\\ 0\\.020079562208951334\ \(0\)\
\-\ nausea\\:\\ 0\\.02005952817995532\ \(0\)\
\-\ enlargement\\:\\ 0\\.020019721248085997\ \(0\)\
\-\ system\\:\\ 0\\.01992169248468156\ \(0\)\
\-\ 18\\:\\ 0\\.019787885972421065\ \(0\)\
\-\ change\\:\\ 0\\.019787885972421065\ \(0\)\
\-\ about\\:\\ 0\\.01954931099348225\ \(0\)\
\-\ 11\\:\\ 0\\.01954931099348225\ \(0\)\
\-\ its\\:\\ 0\\.019322556114553\ \(0\)\
\-\ vomiting\\:\\ 0\\.019322556114553\ \(0\)\
\-\ referred\\:\\ 0\\.019322556114553\ \(0\)\
\-\ confirmed\\:\\ 0\\.019254986351718014\ \(0\)\
\-\ diagnosed\\:\\ 0\\.01891573722459078\ \(0\)\
\-\ abnormalities\\:\\ 0\\.01891573722459078\ \(0\)\
\-\ pt\\:\\ 0\\.018792836733916837\ \(0\)\
\-\ congenital\\:\\ 0\\.018762620331672905\ \(0\)\
\-\ vein\\:\\ 0\\.01871766643537232\ \(0\)\
\-\ including\\:\\ 0\\.01868794056261454\ \(0\)\
\-\ they\\:\\ 0\\.018658406471015757\ \(0\)\
\-\ wbc\\:\\ 0\\.018456836939697272\ \(0\)\
\-\ palpable\\:\\ 0\\.01834551793912505\ \(0\)\
\-\ biopsy\\:\\ 0\\.018304461445812395\ \(0\)\
\-\ weight\\:\\ 0\\.018210071126090733\ \(0\)\
\-\ being\\:\\ 0\\.01819674428023243\ \(0\)\
\-\ or\\:\\ 0\\.01816867364802894\ \(0\)\
\-\ does\\:\\ 0\\.01805265383988411\ \(0\)\
\-\ neoplasm\\:\\ 0\\.01782623453405036\ \(0\)\
\-\ enlarged\\:\\ 0\\.017801754431224788\ \(0\)\
\-\ fever\\:\\ 0\\.017705122488189312\ \(0\)\
\-\ size\\:\\ 0\\.01768127989096227\ \(0\)\
\-\ unremarkable\\:\\ 0\\.017506312033791657\ \(0\)\
\-\ showed\\:\\ 0\\.017393274974156585\ \(0\)\
\-\ should\\:\\ 0\\.01703889797900266\ \(0\)\
\-\ further\\:\\ 0\\.017008001787577158\ \(0\)\
\-\ will\\:\\ 0\\.01680719027996476\ \(0\)\
\-\ examination\\:\\ 0\\.01670999409541776\ \(0\)\
\-\ approximately\\:\\ 0\\.016662159090473805\ \(0\)\
\-\ some\\:\\ 0\\.01643020632014569\ \(0\)\
\-\ only\\:\\ 0\\.01631408109210607\ \(0\)\
\-\ loss\\:\\ 0\\.015909152670194347\ \(0\)\
\-\ level\\:\\ 0\\.015773917707511517\ \(0\)\
\-\ cystic\\:\\ 0\\.015727125801109593\ \(0\)\
\-\ weeks\\:\\ 0\\.015650186707343416\ \(0\)\
\-\ region\\:\\ 0\\.015619769530190166\ \(0\)\
\-\ lymphoma\\:\\ 0\\.015552060958349432\ \(0\)\
\-\ include\\:\\ 0\\.015537149647708344\ \(0\)\
\-\ two\\:\\ 0\\.015507471953364103\ \(0\)\
\-\ 10\\:\\ 0\\.015269705920548812\ \(0\)\
\-\ presented\\:\\ 0\\.015227771871723219\ \(0\)\
\-\ significant\\:\\ 0\\.015077218836794078\ \(0\)\
\-\ lesions\\:\\ 0\\.014997139214827638\ \(0\)\
\-\ than\\:\\ 0\\.014802862466136893\ \(0\)\
\-\ mild\\:\\ 0\\.014802862466136893\ \(0\)\
\-\ who\\:\\ 0\\.01477126973674729\ \(0\)\
\-\ patients\\:\\ 0\\.014690134704722892\ \(0\)\
\-\ prior\\:\\ 0\\.014610412679000763\ \(0\)\
\-\ anterior\\:\\ 0\\.014580116285697843\ \(0\)\
\-\ consistent\\:\\ 0\\.014159206926535828\ \(0\)\
\-\ physical\\:\\ 0\\.014159206926535828\ \(0\)\
\-\ follow\\:\\ 0\\.014077312643775024\ \(0\)\
\-\ chest\\:\\ 0\\.013783899848822145\ \(0\)\
\-\ tissue\\:\\ 0\\.013698425579375811\ \(0\)\
\-\ most\\:\\ 0\\.013590129235374391\ \(0\)\
\-\ demonstrate\\:\\ 0\\.01357555807722822\ \(0\)\
\-\ small\\:\\ 0\\.013470096970202234\ \(0\)\
\-\ were\\:\\ 0\\.013460628986849446\ \(0\)\
\-\ lower\\:\\ 0\\.013343902409932872\ \(0\)\
\-\ up\\:\\ 0\\.012917243822543702\ \(0\)\
\-\ but\\:\\ 0\\.012913045960425395\ \(0\)\
\-\ surgical\\:\\ 0\\.012691894292656684\ \(0\)\
\-\ contrast\\:\\ 0\\.012687897986580779\ \(0\)\
\-\ images\\:\\ 0\\.012079119490238023\ \(0\)\
\-\ has\\:\\ 0\\.011927774522373905\ \(0\)\
\-\ that\\:\\ 0\\.011332173871383015\ \(0\)\
\-\ by\\:\\ 0\\.011089203052398636\ \(0\)\
\-\ not\\:\\ 0\\.010308892349737798\ \(0\)\
